AEGR
Aegerion Pharmaceuticals
AEGR
AEGR
Delisted
AEGR was delisted on the 29th of November, 2016.
131 hedge funds and large institutions have $1.54B invested in Aegerion Pharmaceuticals in 2014 Q1 according to their latest regulatory filings, with 24 funds opening new positions, 56 increasing their positions, 44 reducing their positions, and 39 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less call options, than puts
Call options by funds: $ | Put options by funds: $
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
38% less first-time investments, than exits
New positions opened: 24 | Existing positions closed: 39
71% less funds holding in top 10
Funds holding in top 10: 7 → 2 (-5)
Holders
131
Holding in Top 10
2
Calls
$124M
Puts
$125M
Top Buyers
| 1 | +$87.3M | |
| 2 | +$79.3M | |
| 3 | +$43.1M | |
| 4 |
PC
PointState Capital
New York
|
+$42.7M |
| 5 |
JPMorgan Chase & Co
New York
|
+$30.1M |
Top Sellers
| 1 | -$62.5M | |
| 2 | -$38.1M | |
| 3 | -$37.9M | |
| 4 |
PA
Perceptive Advisors
New York
|
-$31.8M |
| 5 |
American Century Companies
Kansas City,
Missouri
|
-$23.2M |